TRCT
NWBO

Tower Research Capital (TRC)’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Tower Research Capital (TRC)’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15,504
Closed -$8K – 5082
2016
Q3 		$8K Sell
15,504
-5,891
-28% -$2.69K ﹤0.01% 2294
2016
Q2 		$12K Buy
21,395
+20,939
+4,592% +$22.4K ﹤0.01% 2705
2016
Q1 		$1K Sell
456
-2,517
-85% -$4.97K ﹤0.01% 4000
2015
Q4 		$10K Buy
2,973
+988
+50% +$4.75K ﹤0.01% 2223
2015
Q3 		$13K Sell
1,985
-1,513
-43% -$14.1K ﹤0.01% 2136
2015
Q2 		$35K Sell
3,498
-7,595
-68% -$66.5K ﹤0.01% 1648
2015
Q1 		$82K Buy
11,093
+10,865
+4,765% +$73.1K 0.01% 1060
2014
Q4 		$1K Sell
228
-5,408
-96% -$27.7K ﹤0.01% 3911
2014
Q3 		$28K Buy
5,636
+3,359
+148% +$20.6K ﹤0.01% 2054
2014
Q2 		$15K Sell
2,277
-4,016
-64% -$25.6K ﹤0.01% 2079
2014
Q1 		$46K Buy
+6,293
New +$37.3K 0.01% 1162

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Tower Research Capital (TRC)'s NWBO Position: Q4 2016 in Review

Tower Research Capital (TRC) sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 15,504 shares — an estimated $8K sold.

Tower Research Capital (TRC) first reported a position in NWBO in Q1 2014 and held it in 11 quarters. The position peaked at $82K in Q1 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Tower Research Capital (TRC) reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 15,504 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $8K.
  • Tower Research Capital (TRC) first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q1 2014 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s Northwest Biotherapeutics, Inc. Common stock position peaked at $82K in Q1 2015.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.